Deborah G. Grady
#129,350
Most Influential Person Now
Deborah G. Grady's AcademicInfluence.com Rankings
Deborah G. Gradymedical Degrees
Medical
#2113
World Rank
#2513
Historical Rank
Public Health
#306
World Rank
#318
Historical Rank
Deborah G. Gradyphilosophy Degrees
Philosophy
#6218
World Rank
#9216
Historical Rank
Logic
#3403
World Rank
#4554
Historical Rank
Download Badge
Medical Philosophy
Deborah G. Grady's Degrees
- Doctorate Medicine University of California, San Francisco
- Masters Public Health University of California, Berkeley
Why Is Deborah G. Grady Influential?
(Suggest an Edit or Addition)Deborah G. Grady's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. (1998) (6291)
- Hormone therapy to prevent disease and prolong life in postmenopausal women (1992) (2372)
- Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). (2002) (1878)
- The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. (1999) (1638)
- Efficacy of screening mammography. A meta-analysis. (1995) (1147)
- Hormone replacement therapy and endometrial cancer risk: a meta-analysis. (1995) (945)
- Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. (1998) (905)
- Effects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women (2006) (825)
- Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women (2004) (788)
- The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women: Results From the MORE Randomized Trial (2000) (746)
- Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. (1998) (745)
- Postmenopausal Hormone Therapy Increases Risk for Venous Thromboembolic Disease: The Heart and Estrogen/progestin Replacement Study (2000) (696)
- Effect of age, breast density, and family history on the sensitivity of first screening mammography. (1996) (643)
- Incidence of and treatment for ductal carcinoma in situ of the breast. (1996) (632)
- Hormone replacement therapy, heart disease, and other considerations. (1998) (606)
- Glycemic Effects of Postmenopausal Hormone Therapy: The Heart and Estrogen/progestin Replacement Study: A Randomized, Double-Blind, Placebo-Controlled Trial (2003) (587)
- Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). (2002) (507)
- Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women (2004) (492)
- The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. (2007) (471)
- Growth Hormone Replacement in Healthy Older Men Improves Body Composition but Not Functional Ability (1996) (463)
- Weight loss to treat urinary incontinence in overweight and obese women. (2009) (445)
- Serum lipoprotein levels, statin use, and cognitive function in older women. (2002) (441)
- Prevalence of urinary incontinence and associated risk factors in postmenopausal women (1999) (427)
- Adding Heparin to Aspirin Reduces the Incidence of Myocardial Infarction and Death in Patients With Unstable Angina: A Meta-analysis (1996) (400)
- Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. (2002) (396)
- Postmenopausal Hormones and Incontinence: The Heart and Estrogen/Progestin Replacement Study (2001) (381)
- Raloxifene and Cardiovascular Events in Osteoporotic Postmenopausal Women: Four-Year Results From the MORE (Multiple Outcomes of Raloxifene Evaluation) Randomized Trial (2002) (374)
- Positive predictive value of screening mammography by age and family history of breast cancer. (1993) (371)
- Urinary Incontinence in Older Women: Who Is at Risk? (1996) (343)
- Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial. (2002) (331)
- Meta-analysis of exercise testing to detect coronary artery disease in women. (1999) (325)
- Variability and accuracy in mammographic interpretation using the American College of Radiology Breast Imaging Reporting and Data System. (1998) (315)
- Hysterectomy and urinary incontinence: a systematic review (2000) (310)
- Evidence-based guidelines for cardiovascular disease prevention in women. (2004) (243)
- Cognitive decline in women in relation to non-protein-bound oestradiol concentrations (2000) (236)
- Cognitive function in postmenopausal women treated with raloxifene. (2001) (234)
- Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics. (1998) (229)
- Effects of Ultralow-Dose Transdermal Estradiol on Bone Mineral Density: A Randomized Clinical Trial (2004) (224)
- Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis. (1997) (218)
- Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study. (2002) (217)
- Less is more: how less health care can result in better health. (2010) (214)
- Effect of the Women's Health Initiative on Women's Decisions to Discontinue Postmenopausal Hormone Therapy (2003) (210)
- Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. (2005) (200)
- HORMONE REPLACEMENT THERAPY AND THE RISK OF EPITHELIAL OVARIAN CARCINOMA: A META‐ANALYSIS (1998) (195)
- Likelihood ratios for modern screening mammography. Risk of breast cancer based on age and mammographic interpretation. (1996) (195)
- Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. (2001) (194)
- ANTIBIOTICS AT THE TIME OF INDUCED ABORTION: THE CASE FOR UNIVERSAL PROPHYLAXIS BASED ON A META‐ANALYSIS (1996) (191)
- Facial wrinkling in men and women, by smoking status. (1995) (189)
- Predictors of Heart Failure Among Women With Coronary Disease (2004) (188)
- Domestic violence. Risk factors and outcomes. (1991) (187)
- Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group. (1999) (185)
- Noncardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy: Heart and Estrogen/Progestin Replacement Study Follow-Up (HERS II) (2002) (184)
- Comparison of methods to measure low serum estradiol levels in postmenopausal women. (2006) (184)
- Menopausal Symptoms in Older Women and the Effects of Treatment With Hormone Therapy (2002) (180)
- Design and methods of the Raloxifene Use for The Heart (RUTH) study. (2001) (179)
- Adverse Effects Associated With Proton Pump Inhibitors. (2016) (171)
- The WHI estrogen-alone trial--do things look any better? (2004) (167)
- Factor V Leiden, Hormone Replacement Therapy, and Risk of Venous Thromboembolic Events in Women With Coronary Disease (2002) (164)
- Serum Estrogen Levels, Cognitive Performance, and Risk of Cognitive Decline in Older Community Women (1998) (159)
- Safety and Adverse Effects Associated With Raloxifene: Multiple Outcomes of Raloxifene Evaluation (2004) (157)
- The “Costs” of Urinary Incontinence for Women (2006) (157)
- Management of Menopausal Symptoms (2006) (152)
- Evaluation of Abnormal Mammography Results and Palpable Breast Abnormalities (2003) (151)
- Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women's Health Initiative Observational Study. (2011) (142)
- Cardiovascular outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement Study follow-up (HERS II) (2002) (140)
- Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer. (1997) (137)
- Antibiotics in acute bronchitis: a meta-analysis (1999) (131)
- The Sensitivity and Specificity of a Simple Test To Distinguish between Urge and Stress Urinary Incontinence (2006) (130)
- Effects of Raloxifene on Fracture Risk in Postmenopausal Women: The Raloxifene Use for The Heart Trial (2007) (123)
- Hormone Therapy and In-Hospital Survival After Myocardial Infarction in Postmenopausal Women (2001) (122)
- Postmenopausal hormones--therapy for symptoms only. (2003) (121)
- Estrogen receptor 1 polymorphisms and risk of cognitive impairment in older women (2002) (121)
- The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial. (2001) (120)
- Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in The Raloxifene Use for the Heart Trial: Results of Subgroup Analyses by Age and Other Factors (2009) (115)
- Association of total and central obesity with mortality in postmenopausal women with coronary heart disease. (2003) (110)
- Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life. (2006) (103)
- 1,25-Dihydroxyvitamin D3 and muscle strength in the elderly: a randomized controlled trial. (1991) (101)
- Predictors of Difficulty When Discontinuing Postmenopausal Hormone Therapy (2003) (99)
- The Positive Predictive Value of Cervical Smears in Previously Screened Postmenopausal Women: The Heart and Estrogen/progestin Replacement Study (HERS) (2000) (97)
- Venous thromboembolic events associated with hormone replacement therapy. (1997) (97)
- Effect of weight loss on urinary incontinence in overweight and obese women: results at 12 and 18 months. (2010) (97)
- Effect of Raloxifene on Stroke and Venous Thromboembolism According to Subgroups in Postmenopausal Women at Increased Risk of Coronary Heart Disease (2009) (94)
- Renal insufficiency as an independent predictor of mortality among women with heart failure. (2004) (93)
- Postmenopausal Hormone Therapy: Does It Cause Incontinence? (2005) (92)
- Frequency and severity of hot flashes and sleep disturbance in postmenopausal women with hot flashes (2009) (91)
- Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women (2009) (89)
- Benefit of mammography screening in women ages 40–49 years: Current evidence from randomized controlled trials (1995) (88)
- Ineffectiveness of Sertraline for Treatment of Menopausal Hot Flushes: A Randomized Controlled Trial (2007) (88)
- The rise and fall of menopausal hormone therapy. (2005) (83)
- A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer (2010) (83)
- Baseline characteristics of participants in the Raloxifene Use for The Heart (RUTH) trial. (2002) (82)
- An intensive behavioral weight loss intervention and hot flushes in women. (2010) (80)
- Therapeutic controversy: Estrogen replacement in menopause. (1996) (79)
- Clinical practice. Management of menopausal symptoms. (2006) (79)
- Hormone and nonhormone therapy for the maintenance of postmenopausal health: the need for randomized controlled trials of estrogen and raloxifene. (1998) (78)
- Treatment of hyperlipidemia in women. (1995) (78)
- Is Postmenopausal Estrogen Therapy Associated With Neuromuscular Function or Falling in Elderly Women (1995) (76)
- Should we be measuring blood cholesterol levels in young adults? (1993) (75)
- The waning effect of postmenopausal estrogen therapy on osteoporosis. (1993) (72)
- Persistent hot flushes in older postmenopausal women. (2008) (70)
- Restorative yoga in adults with metabolic syndrome: a randomized, controlled pilot trial. (2008) (68)
- Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk. (2008) (66)
- Feasibility and acceptability of restorative yoga for treatment of hot flushes: a pilot trial. (2007) (66)
- Is postmenopausal estrogen therapy associated with neuromuscular function or falling in elderly women? Study of Osteoporotic Fractures Research Group. (1995) (64)
- Results of systematic review of research on diagnosis and treatment of coronary heart disease in women. (2003) (63)
- Uterine and Vaginal Effects of Unopposed Ultralow-Dose Transdermal Estradiol (2005) (63)
- MF101, a selective estrogen receptor &bgr; modulator for the treatment of menopausal hot flushes: a phase II clinical trial (2009) (60)
- Discontinuation of postmenopausal hormone therapy. (2005) (58)
- A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder. (2012) (57)
- Risk factor modification after myocardial infarction. (1988) (56)
- Postmenopausal hormone therapy for prevention of fractures: how good is the evidence? (2001) (54)
- PROMISe trial: a pilot, randomized, placebo-controlled trial of magnetic resonance guided focused ultrasound for uterine fibroids. (2016) (54)
- Restorative yoga and metabolic risk factors: the Practicing Restorative Yoga vs. Stretching for the Metabolic Syndrome (PRYSMS) randomized trial. (2014) (50)
- Diagnosis and treatment of coronary heart disease in women: systematic reviews of evidence on selected topics. (2003) (50)
- Raloxifene and risk for stroke based on the framingham stroke risk score. (2009) (49)
- Hormones To Prevent Coronary Disease in Women: When Are Observational Studies Adequate Evidence? (2000) (48)
- Coronary heart disease in women, randomized clinical trials, HERS and RUTH. (1998) (48)
- Invited Commentary: Does Postmenopausal Hormone Therapy Cause Breast Cancer? (1991) (48)
- Why is a good clinical prediction rule so hard to find? (2011) (48)
- Postmenopausal estrogen therapy and depressive symptoms in older women (2000) (47)
- Hormone replacement therapy and endometrial cancer: are current regimens safe? (1997) (45)
- The Incidence of Unrecognized Myocardial Infarction in Women with Coronary Heart Disease (2001) (44)
- Payments to Physicians: Does the Amount of Money Make a Difference? (2017) (42)
- Clinical trials in stem cell transplantation: guidelines for scientific and ethical review (2008) (42)
- Should prescription of postmenopausal hormone therapy be based on the results of bone densitometry? (1990) (39)
- A 60-year-old woman trying to discontinue hormone replacement therapy. (2002) (38)
- Informed consent in randomized quality improvement trials: a critical barrier for learning health systems. (2014) (38)
- The Day-to-Day Impact of Urogenital Aging: Perspectives from Racially/Ethnically Diverse Women (2009) (37)
- The Effect of Ultralow-Dose Transdermal Estradiol on Urinary Incontinence in Postmenopausal Women (2005) (37)
- Diagnostic tests: another frontier for less is more: or why talking to your patient is a safe and effective method of reassurance. (2011) (36)
- Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women. (2001) (35)
- Sex hormone levels and risk of breast cancer with estrogen plus progestin. (2013) (35)
- Quality Improvement for Quality Improvement Studies. (2017) (34)
- Does a fixed physician reminder system improve the care of patients with coronary artery disease? A randomized controlled trial. (2001) (34)
- Postmenopausal Hormone Therapy: Factors Influencing Women's Decision Making (1997) (33)
- Effect of Raloxifene on all-cause mortality. (2010) (31)
- Oophorectomy as a risk factor for coronary heart disease. (2008) (31)
- Opioids for chronic pain. (2011) (30)
- Maximizing the Benefit of Estrogen Therapy for Prevention of Osteoporosis (1994) (30)
- Too much medicine happens too often: the teachable moment and a call for manuscripts from clinical trainees. (2014) (28)
- Effect of ultra-low-dose transdermal estradiol on breast density in postmenopausal women (2007) (28)
- Commentary: Improving participant recruitment in clinical and translational research. (2011) (26)
- Ascorbic acid supplement use and the prevalence of gallbladder disease. Heart & Estrogen-Progestin Replacement Study (HERS) Research Group. (1998) (26)
- Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years (2006) (25)
- Risk stratification of ambulatory patients suspected of Pneumocystis pneumonia. (1991) (24)
- Statins: underused by those who would benefit (2000) (24)
- 1,25-Dihydroxyvitamin D 3 and Muscle Strength in the Elderly: A Randomized Controlled Trial* (1991) (21)
- How should top-five lists be developed?: what is the next step? (2014) (20)
- Postmenopausal hormones and heart disease. (2001) (19)
- Device-Guided Slow-Paced Respiration for Menopausal Hot Flushes: A Randomized Controlled Trial (2015) (19)
- Is Diabetes Mellitus a Heart Disease Equivalent in Women?: Results From an International Study of Postmenopausal Women in the Raloxifene Use for the Heart (RUTH) Trial (2013) (19)
- The effect of ultralow-dose transdermal estradiol on sexual function in postmenopausal women. (2008) (19)
- Postmenopausal hormone therapy increases risk of deep vein thrombosis and pulmonary embolism. (1998) (18)
- Sodium Polystyrene Sulfonate for Hyperkalemia. (2019) (17)
- Alternatives to estrogen for treatment of hot flashes: are they effective and safe? (2006) (17)
- Physician Adherence to Breast Cancer Screening Recommendations. (2017) (16)
- Hot Flushes, Bone Mineral Density, and Fractures in Older Postmenopausal Women (2007) (16)
- Miniature ambulatory skin conductance monitor and algorithm for investigating hot flash events (2014) (16)
- Effect of hormone therapy on mortality rates among women with heart failure and coronary artery disease. (2005) (15)
- The lumpy breast. (1988) (15)
- Heart and estrogen/progestin replacement study follow-up (HERS-II) 1. Cardiovascular outcomes during 6.8 years of hormone therapy (2002) (14)
- Research Using Existing Data (14)
- Strengthening institutional review board review of highly innovative interventions in clinical trials. (2009) (13)
- Postmenopausal hormone treatment. (2009) (13)
- Persistent Hot Flushes in Older Postmenopausal Women (2008) (13)
- Placebo adherence and mortality in the Heart and Estrogen/Progestin Replacement Study. (2012) (13)
- Soy isoflavones for prevention of menopausal bone loss and vasomotor symptoms: comment on "Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms". (2011) (13)
- Evidence in clinical practice. (2012) (13)
- Left Ventricular Pseudoaneurysm: Diagnosis by Cine Magnetic Resonance Imaging (2000) (13)
- The Impending Crisis of Access to Safe Abortion Care in the US. (2022) (12)
- Response to Letter Regarding Article “Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in the Raloxifene Use for the Heart Trial: Results of Subgroup Analyses by Age and Other Factors” (2009) (12)
- Postmenopausal hormone therapy, SERMs, and coronary heart disease in women (1999) (11)
- A miniature sternal skin-attached hot flash recorder (2007) (11)
- Caring Wisely: A Program to Support Frontline Clinicians and Staff in Improving Healthcare Delivery and Reducing Costs. (2017) (11)
- Length of hospitalization and mortality for bleeding during treatment with warfarin, dabigatran, or rivaroxaban (2018) (10)
- BENEFIT OF MAMMOGRAPHY SCREENING IN WOMAN AGES 40-49 YEARS : CURRENT EVIDENCE FROM RANDOMIZED CONTROLLED TRIALS. AUTHORS'REPLY (1995) (10)
- Asymptomatic Microscopic Hematuria-Rethinking the Diagnostic Algorithm. (2017) (10)
- The postmenopausal estrogen/breast cancer controversy. (1993) (10)
- Undertreatment improves, but overtreatment does not. (2013) (10)
- I Have a Cold-What Do I Need to Know? (2018) (9)
- Criteria for waiver of informed consent for quality improvement research-reply. (2015) (9)
- Cardiac autonomic function and hot flashes among perimenopausal and postmenopausal women (2017) (9)
- Postmenopausal hormone therapy (1993) (8)
- Electrocardiograms of menopausal women with coronary heart disease or at increased risk for its occurrence. (2010) (8)
- Editor's Note--to make the case--evidence is required: comment on "Making the case for selective use of statins in the primary prevention setting". (2011) (8)
- Is a shorter hot flash diary just as good as a 7-day diary? (2009) (7)
- Raloxifene and colorectal cancer. (2005) (7)
- A Randomized Controlled Trial of Device-Guided Slow-Paced Respiration In Women with Overactive Bladder Syndrome. (2019) (7)
- Reasons for overtreatment: comment on "Too little? Too much? Primary care physicians' views on US health care". (2011) (6)
- Urinary Incontinence in Older Women: S-11. (1995) (6)
- Invited commentary--illuminating physicians' financial relationships with industry. (2011) (6)
- Hormone treatment--misconceptions and agreements. (2002) (6)
- Recommendations From Breast Cancer Centers for Frequent Screening Mammography in Younger Women May Do More Harm Than Good. (2021) (5)
- Continuous transdermal nitroglycerin therapy for menopausal hot flashes: a single-arm, dose-escalation trial (2016) (5)
- Consistency of Repeated Isokinetic Testing: Effect of Different Examiners, Sites, and Protocols (1991) (5)
- Improving care at the end of life. (2011) (5)
- Beyond the bladder: poor sleep in women with overactive bladder syndrome. (2019) (5)
- Evidence for Postmenopausal Hormone Therapy to Prevent Chronic Conditions: Success, Failure, and Lessons Learned. (2017) (5)
- Developing methods for less is more. (2014) (4)
- Persistence of Sexual Harassment and Gender Bias in Medicine Across Generations-Us Too. (2018) (4)
- Skin Thickness, Estrogen Use, and Bone Mass in Older Women (1994) (4)
- Postmenopausal hormone therapy--good for smokers? (1999) (4)
- Addressing Ethical Lapses in Research. (2017) (4)
- The Next Frontier of Less Is More-From Description to Implementation. (2021) (3)
- Estrogen Therapy in Postmenopausal Women (2016) (3)
- Rethinking the Approach to Managing Postmenopausal Vulvovaginal Symptoms. (2018) (3)
- Exercise, Hormone Therapy, and Lipoproteins in Women (1996) (3)
- Moving Beyond Guidelines-Use of Value-Based Preoperative Testing. (2021) (3)
- Another reason to be cautious about imaging: comment on "association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism". (2012) (2)
- Carpal tunnel syndrome. (1988) (2)
- Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women (2018) (2)
- Making Decisions About Screening Mammography in Older Women Comment on “Older Patient Experiences in the Mammography Decision-Making Process” (2012) (2)
- Myocardial infarction during menses: lessons from trials and errors. (2003) (2)
- Meta-analyses and large randomized, controlled trials. (1998) (2)
- The flip side of performance measures: limiting overtreatment. (2012) (2)
- Abstract 11583: Length of Hospital Stay and All-Cause Mortality Among Adults With Atrial Fibrillation Hospitalized for Bleeding During Treatment With Warfarin, Dabigatran, or Rivaroxaban (2015) (2)
- Drinking More Water for Prevention of Recurrent Cystitis. (2018) (2)
- Helping women stop postmenopausal hormone therapy. (2006) (2)
- The Flip Side of Performance Measures: Comment on “The Other Side of Quality Improvement in Diabetes for Seniors” (2012) (2)
- Planning for closeout--from Day One. (2008) (2)
- A Simple Approach to Reducing Inappropriate Use of Central Venous Catheters. (2015) (2)
- On board with the Choosing Wisely campaign. (2014) (2)
- False Information About Breast Cancer Screening-Reply. (2018) (2)
- Hematuria Practice Guidelines That Explicitly Consider Harms and Costs. (2019) (2)
- A Miniature Skin-Attached Hot Flash Recorder (2007) (2)
- The "top 5" health care activities for which less is more: comment on "The 'top 5' lists in primary care". (2011) (1)
- P2-390 Effects of ultra low-dose transdermal estradiol on cognitive function: Results of a randomized clinical trial (2006) (1)
- Improving quality of care at the end of life. (2012) (1)
- Hormone Therapy for Prevention of Urinary Incontinence: The HERS Study (2003) (1)
- Inappropriate Use of Steroids for Acute Respiratory Infection. (2018) (1)
- I Just Feel Terrible: Comment on "Why Physicians Work When Sick"I Just Feel Terrible. (2012) (1)
- Consideration of Early Stopping and Other Challenges in Monitoring the Heart and Estrogen/Progestin Replacement Study (2006) (1)
- Abstract 2181: Risk of Stroke in the Raloxifene Use for The Heart (RUTH) Trial (2006) (1)
- After a devastating birth injury hope. (2009) (1)
- 95044464 Is postmenopausal estrogen therapy associated with neuromuscular function or falling in elderly women (1995) (1)
- The Efficacy of Mammography and Screening for Breast Cancer-Reply (1995) (1)
- Advancing medical professionalism and the choosing wisely campaign--reply. (2015) (1)
- Why Is Nonadherence to Cancer Screening Associated With Increased Mortality? (2019) (1)
- ESTROGEN AND PROGESTIN FOR THE SECONDARY PREVENTION OF CORONARY HEART DISEASE IN POSTMENOPAUSAL WOMEN (1999) (1)
- Paper 32: The ???Costs??? of Urinary Incontinence in Women (2005) (1)
- Testing before seeing the patient. (2015) (1)
- and Other Endometrial Abnormalities Endovaginal Ultrasound to Exclude Endometrial Cancer (2000) (1)
- How Much Vitamin D Is Enough? (2015) (1)
- Menopausal Hormone Therapy for Prevention of Chronic Conditions: When Is Enough, Enough? (2022) (1)
- Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women Expert Panel / Writing Group * (2004) (1)
- Advance Care Planning and the Cost of Pragmatism. (2021) (1)
- Hormone Replacement Therapy: Factors Influencing Womenʼs Decision-Making: S-2. (1995) (0)
- Conflicts of Interest and Authors of Commentaries in Medical Journals. (2021) (0)
- Let's Just Check That Potassium One More Time . . . : Comment on “Last Orders: Follow-up of Tests Ordered on the Day of Hospital Discharge” (2012) (0)
- Appropriate Opioid Prescribing for Acute Pain. (2021) (0)
- Why physicians order tests. (2013) (0)
- The Electronic Health Record as Practice-Improvement Coach. (2018) (0)
- A role for opioids in chronic pain management-reply. (2012) (0)
- Simplification of Insulin Regimens in Patients With Type 2 Diabetes. (2016) (0)
- Contributors (2012) (0)
- An Alternative to Sodium Polystyrene Sulfonate and Patiromer for the Treatment of Hyperkalemia-Reply. (2019) (0)
- Treatment of Borderline Elevated Thyrotropin Levels (2017) (0)
- Routine Laboratory Tests in Hospitalized Patients-The Registered Nurse's Role. (2017) (0)
- Rigor in Quality Improvement Studies and the Role of Time-Series Methodologies-Reply. (2018) (0)
- Sertraline Ineffective for Menopausal Hot Flashes (2008) (0)
- POSTMENOPAUSAL HORMONE THERAPY. AUTHORS' REPLY (1993) (0)
- Conservative use of prescription drugs: comment on "Communicating uncertainties about prescription drugs to the public". (2011) (0)
- In Reply. (2017) (0)
- Protecting NIH's Integrity and Trustworthiness in Public-Private Partnerships. (2018) (0)
- Coronary Heart Disease Testing Before Kidney Transplant-A Call for Revised Guidance. (2023) (0)
- Preoperative Medical Consultation-Time to Reevaluate a Questionable Process. (2023) (0)
- Patient experience of overtreatment. (2011) (0)
- Baseline Endogenous Estradiol and the Association of Hormone Therapy with Breast Cancer Risk, the Women's Health Initiative Clinical Trials. (2009) (0)
- [Table, Results of Literature Searches]. (2003) (0)
- Overuse of Levothyroxine in Patients With Subclinical Hypothyroidism: Time to "Leve"-Out-Thyroxine. (2021) (0)
- I just feel terrible. (2012) (0)
- Hormone Therapy and Risk for Venous Thromboembolism: Comments and Correction (2001) (0)
- Hormone treatment - Misconceptions and agreements [4] (multiple letters) (2002) (0)
- Abstract: 1057 RALOXIFENE AND STROKE RISK BASED ON THE FRAMINGHAM STROKE RISK SCORE (2009) (0)
- Oral Poster 45: The Effect of Ultra Low-dose Transdermal Estradiol on Urinary Incontinence (UI) in Postmenopausal Women (2004) (0)
- Abstract B99: Hot flashes, hormone therapy, and breast cancer risk: The Women's Health Initiative Clinical Trials (2010) (0)
- Iconographies supplémentaires de l'article : Oophorectomy as a risk factor for coronary heart disease (2011) (0)
- POSTMENOPAUSAL HORMONE THERAPY INCREASES RISK OF DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM. AUTHORS' REPLY (1999) (0)
- Appendix C: Full Text Article Abstraction Form (2003) (0)
- Feasibility and acceptability of yoga for treatment of hot flushes: A pilot trial (2006) (0)
- Letters to the Editor. (2016) (0)
- Let's Get Another Tube-Just in Case. (2017) (0)
- Spinal augmentation for vertebral fracture. (2013) (0)
- Financial Profit: Not the Mission of Medicine (2021) (0)
- 95039031 Hormone replacement therapy and endometrial cancer risk: A meta-analysis (1995) (0)
- The Art of Listening (2011) (0)
- Placebo adherence and mortality in the Hormone and Estrogen/ Progestin Replacement Study (2012) (0)
- A different perspective regarding prostate-specific antigen testing: in reply. (2012) (0)
- Introducing JAMA Internal Medicine Patient Pages. (2018) (0)
- Analysis strategies for randomized studies with continuous outcomes: Post-intervention measurements versus change scores (1991) (0)
- Hormone treatment: misconceptions and agreements. Authors' reply (2002) (0)
- Search Images and Extrapolation Risk-Reply. (2017) (0)
- Postmenopausal hormone therapy and mortality. (1997) (0)
- Risk/benefit considerations for hormone therapy in the postmenopausal woman: Developing a health profile (2006) (0)
- Sleeping on the Street. (2017) (0)
- Postmenopausal hormone therapy [6] (1993) (0)
- Announcing the Teachable Moment Editorial Fellowship. (2018) (0)
- Approaches to increase physical activity. (2014) (0)
- The periodic health examination. (1980) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Deborah G. Grady?
Deborah G. Grady is affiliated with the following schools:
